Citigroup’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
19,090
+14,668
| +332% | +$165K | ﹤0.01% | 3314 |
|
|
2025
Q1 | $25.2K | Sell |
4,422
-75,038
| -94% | -$428K | ﹤0.01% | 4276 |
|
|
2024
Q4 | $780K | Buy |
79,460
+50,609
| +175% | +$497K | ﹤0.01% | 2751 |
|
|
2024
Q3 | $235K | Buy |
28,851
+9,581
| +50% | +$78.1K | ﹤0.01% | 3475 |
|
|
2024
Q2 | $258K | Sell |
19,270
-14,964
| -44% | -$200K | ﹤0.01% | 3047 |
|
|
2024
Q1 | $1.59M | Buy |
34,234
+20,756
| +154% | +$963K | ﹤0.01% | 2008 |
|
|
2023
Q4 | $911K | Sell |
13,478
-1,182
| -8% | -$79.9K | ﹤0.01% | 2228 |
|
|
2023
Q3 | $1.06M | Sell |
14,660
-4,432
| -23% | -$321K | ﹤0.01% | 1864 |
|
|
2023
Q2 | $1.42M | Sell |
19,092
-1,126
| -6% | -$83.8K | ﹤0.01% | 1969 |
|
|
2023
Q1 | $1.08M | Sell |
20,218
-830
| -4% | -$44.2K | ﹤0.01% | 1945 |
|
|
2022
Q4 | $1.42M | Buy |
21,048
+3,609
| +21% | +$244K | ﹤0.01% | 1746 |
|
|
2022
Q3 | $2.18M | Sell |
17,439
-583
| -3% | -$72.7K | ﹤0.01% | 1547 |
|
|
2022
Q2 | $1.72M | Sell |
18,022
-11,007
| -38% | -$1.05M | ﹤0.01% | 1680 |
|
|
2022
Q1 | $4.68M | Buy |
29,029
+28,291
| +3,833% | +$4.56M | ﹤0.01% | 1222 |
|
|
2021
Q4 | $245K | Buy |
+738
| New | +$245K | ﹤0.01% | 3486 |
|